|
Hi Lani,
I undestand that companies are very reluctant to carry out clinical trial because it is v. time consuming+ extremely costly, surely adding more regulations to this is not going to help our cause.
From a (happy) guinea pig point of view for example I am annoyed that FDA could stop me from having Trovax (another vaccine) because I already have had the peptide UW vaccine. When I understand that UW would be quite keen on me having it aswell since they are hypothetising that it may confer better protection.
I do not know exactly how clinical reseach operates here or in the EU, however my instinct is to say that ( for life threatening conditions) I am very much in favour of relaxing the regulations as oppose to go the other way! I am very much in favour also to have compationate access to trials. If you are a stage 4 you know what true desesperation taste like, and this feeling is, in my opinion, the most inhumane aspect of closing off research access and or making it difficult and costly.
I am doubdful that rats and mice get better protection than human..sounds rather ludicrous comment made to shock people and get media attention.
Thanks AA for the book reference I will order it.
Lani I really respect your views and comments on this. And once again thank you once more for your interesting post as always.
__________________

35 y/o
June 06: BC stage I
Grade 3; ER/PR neg
Her-2+++; lumpectomies
Aug 06: Stage IV
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006
NED til Oct 09
Recurrence Oct 2009: to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised..
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo..
superior vena cava blocked: stent but face remains puffy
April 2012: Teresa Trial, randomised to TDM1
Nov 2012 progressing on TDM1
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes.
Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.
'Under no circumstances should you lose hope..' Dalai Lama
|